Type:
Educational Exhibit
Keywords:
Abdomen, CT, Contrast agent-intravenous, Cancer
Authors:
D. Paul, M. Feeney
DOI:
10.26044/ranzcr2022/R-0015
Background
Uterine leiomyomas are the most commonly reported benign gynaecological smooth muscle tumour afflicting women of reproductive age.1 Women who underwent primary surgery such as a hysterectomy at the mean age of 38.5 years were subsequently diagnosed with BML featuring pulmonary metastases at a mean age of 47.3 years.2 Monoclonal spread and peritoneal seeding from fragments post-surgery are the current prevailing theories underlying the pathogenesis of BML.1-3 Microscopically, BML demonstrates smooth muscle cell differentiation with immunohistochemistry revealing mild tumour cell proliferation.1-3 Patients diagnosed with BML undergo surveillance, hormonal therapy and ultimately surgical removal of the metastases.2